Two Sigma Securities’s BioLineRX BLRX Stock Holding History

Two Sigma Securities’s Portfolio BLRX Stock Details BLRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-13,816	Closed	-$63.1K	–	1421
2025 Q2	$63.1K	Buy	+13,816	New	+$51.1K	0.01%	1092
2025 Q1	–	Sell	-883	Closed	-$7.56K	–	1498
2024 Q4	$7.56K	Buy	+883	New	+$13K	﹤0.01%	1459
2024 Q3	–	Sell	-1,156	Closed	-$26.3K	–	2890
2024 Q2	$26.3K	Buy	1,156 +724	+168%	+$19.4K	﹤0.01%	2658
2024 Q1	$19.3K	Buy	+432	New	+$21.7K	﹤0.01%	2679
2023 Q2	–	Sell	-604	Closed	-$21.4K	–	2797
2023 Q1	$21.4K	Buy	+604	New	+$15.9K	﹤0.01%	2353
2022 Q4	–	Sell	-760	Closed	-$28K	–	2606
2022 Q3	$28K	Buy	+760	New	+$43.4K	﹤0.01%	2262
2019 Q1	–	Sell	-94	Closed	-$25K	–	1843
2018 Q4	$25K	Buy	+94	New	+$45.2K	﹤0.01%	1968
2016 Q3	–	Sell	-30	Closed	-$14K	–	663
2016 Q2	$14K	Sell	30 -4	-12%	-$2.24K	0.01%	391
2016 Q1	$21K	Buy	+34	New	+$21.4K	0.03%	236

Other funds holding BLRX

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

RhumbLine Advisers Boston, Massachusetts $117B AUM 29.66% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

NRG

Nemes Rush Group Novi, Michigan $1.05B AUM 30.08% 1-Year Est. Return

NewEdge Advisors New Orleans, Louisiana $27.7B AUM 22.98% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Rockefeller Capital Management New York $56.4B AUM 24.96% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Two Sigma Securities's BLRX Position: Q3 2025 in Review

Two Sigma Securities sold out of BioLineRX (BLRX) in Q3 2025, closing a stake of 13,816 shares — an estimated $63.1K sold.

Two Sigma Securities first reported a position in BLRX in Q1 2016 and held it in 9 quarters. The position peaked at $63.1K in Q2 2025. 14 funds tracked by Wall St. Rank hold BLRX as of Q3 2025.

Two Sigma Securities reported no remaining BioLineRX position as of Q3 2025 after selling out during the quarter.
Two Sigma Securities sold 13,816 BioLineRX shares in Q3 2025, an estimated $63.1K.
Two Sigma Securities first reported a position in BioLineRX in Q1 2016 and held it in 9 quarters.
Two Sigma Securities's BioLineRX position peaked at $63.1K in Q2 2025.
14 funds tracked by Wall St. Rank held BioLineRX as of Q3 2025.

Based on Two Sigma Securities's 13F filing for Q3 2025, filed 14 Nov 2025.